203 related articles for article (PubMed ID: 38303608)
21. BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma.
Zhu Q; Gu X; Wei W; Wu Z; Gong F; Dong X
Cancer Med; 2023 Jan; 12(2):1572-1587. PubMed ID: 35778964
[TBL] [Abstract][Full Text] [Related]
22. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract][Full Text] [Related]
23. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
24. BRD9-mediated control of the TGF-β/Activin/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells.
Wang X; Song C; Ye Y; Gu Y; Li X; Chen P; Leng D; Xiao J; Wu H; Xie S; Liu W; Zhao Q; Chen D; Chen X; Wu Q; Chen G; Zhang W
Nucleic Acids Res; 2023 Nov; 51(21):11634-11651. PubMed ID: 37870468
[TBL] [Abstract][Full Text] [Related]
25. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.
Middeljans E; Wan X; Jansen PW; Sharma V; Stunnenberg HG; Logie C
PLoS One; 2012; 7(3):e33834. PubMed ID: 22442726
[TBL] [Abstract][Full Text] [Related]
26. Bromodomain-containing proteins BRD1, BRD2, and BRD13 are core subunits of SWI/SNF complexes and vital for their genomic targeting in Arabidopsis.
Yu Y; Fu W; Xu J; Lei Y; Song X; Liang Z; Zhu T; Liang Y; Hao Y; Yuan L; Li C
Mol Plant; 2021 Jun; 14(6):888-904. PubMed ID: 33771698
[TBL] [Abstract][Full Text] [Related]
27. BRD9 Inhibition by Natural Polyphenols Targets DNA Damage/Repair and Apoptosis in Human Colon Cancer Cells.
Kapoor S; Damiani E; Wang S; Dharmanand R; Tripathi C; Tovar Perez JE; Dashwood WM; Rajendran P; Dashwood RH
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297001
[TBL] [Abstract][Full Text] [Related]
28. The SWI/SNF complex in cancer - biology, biomarkers and therapy.
Mittal P; Roberts CWM
Nat Rev Clin Oncol; 2020 Jul; 17(7):435-448. PubMed ID: 32303701
[TBL] [Abstract][Full Text] [Related]
29. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway.
Dou C; Sun L; Wang L; Cheng J; Wu W; Zhang C; Xu Q; Tu K; Liu J
Cell Death Dis; 2020 Sep; 11(9):730. PubMed ID: 32908135
[TBL] [Abstract][Full Text] [Related]
30. BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.
Kurata K; Samur MK; Liow P; Wen K; Yamamoto L; Liu J; Morelli E; Gulla A; Tai YT; Qi J; Hideshima T; Anderson KC
Clin Cancer Res; 2023 May; 29(9):1807-1821. PubMed ID: 36780189
[TBL] [Abstract][Full Text] [Related]
31. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
Liu Z; Zhao P
J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
[TBL] [Abstract][Full Text] [Related]
32. Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity.
Wang L; Oh TG; Magida J; Estepa G; Obayomi SMB; Chong LW; Gatchalian J; Yu RT; Atkins AR; Hargreaves D; Downes M; Wei Z; Evans RM
Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34446564
[TBL] [Abstract][Full Text] [Related]
33. BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition.
Del Gaudio N; Di Costanzo A; Liu NQ; Conte L; Migliaccio A; Vermeulen M; Martens JHA; Stunnenberg HG; Nebbioso A; Altucci L
Cell Death Dis; 2019 Apr; 10(5):338. PubMed ID: 31000698
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors.
Zheng P; Zhang J; Ma H; Yuan X; Chen P; Zhou J; Zhang H
Bioorg Med Chem; 2019 Apr; 27(7):1391-1404. PubMed ID: 30824168
[TBL] [Abstract][Full Text] [Related]
35. BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.
Sevinç K; Sevinç GG; Cavga AD; Philpott M; Kelekçi S; Can H; Cribbs AP; Yıldız AB; Yılmaz A; Ayar ES; Arabacı DH; Dunford JE; Ata D; Sigua LH; Qi J; Oppermann U; Onder TT
Stem Cell Reports; 2022 Dec; 17(12):2629-2642. PubMed ID: 36332631
[TBL] [Abstract][Full Text] [Related]
36. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
Brien GL; Remillard D; Shi J; Hemming ML; Chabon J; Wynne K; Dillon ET; Cagney G; Van Mierlo G; Baltissen MP; Vermeulen M; Qi J; Fröhling S; Gray NS; Bradner JE; Vakoc CR; Armstrong SA
Elife; 2018 Nov; 7():. PubMed ID: 30431433
[TBL] [Abstract][Full Text] [Related]
37. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
38. BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma.
Hipólito A; Xavier R; Brito C; Tomás A; Lemos I; Cabaço LC; Silva F; Oliva A; Barral DC; Vicente JB; Gonçalves LG; Pojo M; Serpa J
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166983. PubMed ID: 38070581
[TBL] [Abstract][Full Text] [Related]
39. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
Yang Q; Vafaei S; Falahati A; Khosh A; Bariani MV; Omran MM; Bai T; Siblini H; Ali M; He C; Boyer TG; Al-Hendy A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255982
[TBL] [Abstract][Full Text] [Related]
40. Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.
Karim RM; Chan A; Zhu JY; Schönbrunn E
J Med Chem; 2020 Mar; 63(6):3227-3237. PubMed ID: 32091206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
